|
Advances in Pancreatic Cancer Care:
CME Information from Jefferson Medical College
 Continuing Medical Education (CME) credits are available to physicians who sign up by clicking here for the simulcast on Advances in Pancreatic Cancer Care via the Internet. Viewers will be able to ask questions online as well. A replay version of the webcast will be available for viewing at this site beginning September 19th.
Upon completion of this program, participants should be able to:
- Identify when a mini-Whipple procedure should be considered a viable therapeutic option to treat pancreatic cancer.
- Differentiate the advantages and risks of the mini-Whipple and the “classic” Whipple.
- Discuss modern imaging techniques for pancreatic tumors.
- Discuss the use of endoscopic ultrasound for diagnosis and staging of pancreatic tumors.
- Discuss the techniques/tricks of the mini-Whipple operation.
- Discuss the benefits of glucose sensors, and their future role in tight glycemic control.
- Discuss the recent developments in molecular genetics of pancreatic cancer.
- Discuss the risks and benefits of this type of pancreatic surgery.
Jefferson Medical College of Thomas Jefferson University is accredited by the ACCME to provide continuing medical education for physicians. Jefferson Medical College designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Each physician should claim only those credits that he/she actually spent in the educational activity.
Disclosure of Significant Relationships with Relevant Commercial Companies and Organizations
Jefferson Medical College endorses the Standards of the Accreditation Council for Continuing Medical Education and the Guidelines for Commercial Support. Every effort has been made to encourage faculty to disclose any commercial relationships or personal benefit with commercial companies whose products are discussed in the educational presentation. Disclosure of a relationship is not intended to suggest or condone bias in any presentations, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
The speaker(s) listed below have declared that they have no financial arrangements or affiliations with any corporate organization offering financial support or grant monies for this CME program or with any corporate organization whose product(s) will be discussed in their presentation(s):
Jonathan Brody, Ph.D.
Thomas Kowalski, MD
Charles Yeo, MD
The following speaker(s) have declared financial interest(s) and/or affiliations:
Jeffrey Joseph, DO |
Grant/Research Support |
St. Jude Medical; Medtronic Diabetes; Johnson and Johnson- Lifescan; Abbott Diabetes Care |
Consultant |
Johnson and Johnson- Lifescan |
Scientific Advisor |
St. Jude Medical; Johnson and Johnson- Lifescan; Abbott Diabetes Care |
Product/Speakers' Bureau |
Abbott Diabetes Care |
Stock Shareholder |
Medtronic Diabetes; Johnson and Johnson- Lifescan |
Donald Mitchell, MD |
Grant/Research Support |
Possible support for TJU research from Philips |
Consultant |
Consultant & Blinded Reader Ethicon(Johnson & Johnson); Consultant & Blinded Reader BioImaging |
The following speaker(s) have indicated that they will/may include discussion of investigational or off-label use of products.
Jeffrey Joseph, DO
|
